October 28, 2019 / 9:48 PM / 24 days ago

Merck wins second chance to arbitrate rotavirus vaccine antitrust case

Merck & Co Inc on Monday won a second chance to argue that three pediatric medical practices should be forced to arbitrate claims they brought in a proposed class action alleging it illegally stifled competition to its rotavirus vaccine RotaTeq.

The 3rd U.S. Circuit Court of Appeals in Philadelphia ruled that a judge should have allowed limited discovery to assess whether the clinics were subject to an arbitration agreement with Merck before denying its motion to compel arbitration.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2WjqDCX

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below